Moreover, recombinant TRAIL was demonstrated to inhibit autoimmune diseases in numerous animal models, such as those of rheumatoid arthritis, autoimmune encephalomyelitis, and autoimmune thyroiditis68,69. Here, TNFSF10 is linked to autoimmune disease.